Hendrik Jan Smit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hendrik Jan Smit has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
D.J. Mela
Unilever R&D, Vlaardingen, The Netherlands
1 shared publication- David J. Mela
Valkenswaard, The Netherlands
1 shared publication E Keenan
Department of Experimental Psychology, University of Bristol, Bristol, UK
1 shared publicationE M R Kovacs
Unilever North America, Englewood Cliffs, NJ, USA
1 shared publicationE. Keenan
Functional Food Centre, Oxford Brookes University, Oxford OX3 0BP, UK
1 shared publicationE.M.R. Kovacs
Unilever North America, Englewood Cliffs NJ, USA
1 shared publication
Latest Publications
- 22 September 2010
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 65 (1) , 81-86
No efficacy of processed Fabuless (Olibra) in suppressing appetite or food intake
Background/Objectives: To investigate the feasibility of Fabuless (previously called Olibra and Reducal) as a food ingredient for food intake and appetite reduction, by assessing the effects of food processing on efficacy. Subjects/Methods: In total, 24 healthy volunteers (16 female, 8 male; age: 18–43 years; body mass index: 18–37 kg/m2) took part in a randomized, placebo-controlled, double-blinded, cross-over trial. Yoghurt-based meal replacement drinks (containing processed or unprocessed Fabuless, or a control fat) were followed by an ad libitum lunch and evening meal (dinner). Key outcome measures were energy intake and self-reported appetite ratings. Results: Compared with control, only unprocessed Fabuless reduced subsequent energy intake, although only during dinner (P<0.01; control, processed and unprocessed: 4.3, 3.9 and 4.2 MJ, respectively) and not during lunch (3.6, 3.7 and 3.6 MJ). Self-reported appetite scores did not differ between treatments. Conclusions: Although modest effects of unprocessed Fabuless were seen on food intake, but not on appetite, the ingredient was not robust to common food-manufacturing processes (thermal and shear processing). Claims on reduced food intake and appetite relating to this ingredient in food products are, therefore, only valid if functionality has been demonstrated after all relevant processing and storage steps.
- 22 September 2010
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 65 (1) , 81-86
No efficacy of processed Fabuless (Olibra) in suppressing appetite or food intake
Background/Objectives: To investigate the feasibility of Fabuless (previously called Olibra and Reducal) as a food ingredient for food intake and appetite reduction, by assessing the effects of food processing on efficacy. Subjects/Methods: In total, 24 healthy volunteers (16 female, 8 male; age: 18–43 years; body mass index: 18–37 kg/m2) took part in a randomized, placebo-controlled, double-blinded, cross-over trial. Yoghurt-based meal replacement drinks (containing processed or unprocessed Fabuless, or a control fat) were followed by an ad libitum lunch and evening meal (dinner). Key outcome measures were energy intake and self-reported appetite ratings. Results: Compared with control, only unprocessed Fabuless reduced subsequent energy intake, although only during dinner (P<0.01; control, processed and unprocessed: 4.3, 3.9 and 4.2 MJ, respectively) and not during lunch (3.6, 3.7 and 3.6 MJ). Self-reported appetite scores did not differ between treatments. Conclusions: Although modest effects of unprocessed Fabuless were seen on food intake, but not on appetite, the ingredient was not robust to common food-manufacturing processes (thermal and shear processing). Claims on reduced food intake and appetite relating to this ingredient in food products are, therefore, only valid if functionality has been demonstrated after all relevant processing and storage steps.
- 19 August 2010
- Published by Springer Nature
- No. 200,p. 201-234
Theobromine and the Pharmacology of Cocoa
The effects of theobromine in man are underresearched, possibly owing to the assumption that it is behaviourally inert. Toxicology research in animals may appear to provide alarming results, but these cannot be extrapolated to humans for a number of reasons. Domestic animals and animals used for racing competitions need to be guarded from chocolate and cocoa-containing foods, including foods containing cocoa husks. Research ought to include caffeine as a comparative agent, and underlying mechanisms need to be further explored. Of all constituents proposed to play a role in our liking for chocolate, caffeine is the most convincing, though a role for theobromine cannot be ruled out. Most other substances are unlikely to exude a psychopharmacological effect owing to extremely low concentrations or the inability to reach the blood–brain barrier, whilst chocolate craving and addiction need to be explained by means of a culturally determined ambivalence towards chocolate.
- 19 August 2010
- Published by Springer Nature
- No. 200,p. 201-234
Theobromine and the Pharmacology of Cocoa
The effects of theobromine in man are underresearched, possibly owing to the assumption that it is behaviourally inert. Toxicology research in animals may appear to provide alarming results, but these cannot be extrapolated to humans for a number of reasons. Domestic animals and animals used for racing competitions need to be guarded from chocolate and cocoa-containing foods, including foods containing cocoa husks. Research ought to include caffeine as a comparative agent, and underlying mechanisms need to be further explored. Of all constituents proposed to play a role in our liking for chocolate, caffeine is the most convincing, though a role for theobromine cannot be ruled out. Most other substances are unlikely to exude a psychopharmacological effect owing to extremely low concentrations or the inability to reach the blood–brain barrier, whilst chocolate craving and addiction need to be explained by means of a culturally determined ambivalence towards chocolate.